SCHEMBL11956074

SCHEMBL11956074

CCN1CCC2(CC1)CCN(c1ccc(C(F)(F)F)cc1)CC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ RAD52 P43351 1/20 0.45
▸ GFER P55789 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ CYP3A4 P08684 3/20 0.44
▸ TSHR P16473 2/20 0.44
▸ CYP2D6 P10635 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ CHRNA7 P36544 1/20 0.44
▸ KCNH2 Q12809 2/20 0.42
▸ EBP Q15125 1/20 0.42
▸ MMP2 P08253 1/20 0.41
▸ MMP3 P08254 1/20 0.41
▸ MMP9 P14780 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11955829 0.91 CA12 (0.43) CA12CA2CA9KDM4EGAA
SCHEMBL2056240 0.85 GAA (0.61) CA12CA2CA9KDM4EGAA
SCHEMBL11955399 0.83 KDM4E (0.49) CA12CA2CA9KDM4EGAA
SCHEMBL14996515 0.83 HIF1A (0.48) CA12CA2CA9KDM4EGAA
SCHEMBL11947802 0.80 TSHR (0.45) CA12CA2CA9CYP3A4TSHR
SCHEMBL11956080 0.80 CYP2D6 (0.59) SMN1; SMN2CYP3A4TSHRCYP2D6CYP1A2
SCHEMBL13050665 0.78 CYP2D6 (0.63) CA12CA2CA9MAPTSMN1; SMN2
SCHEMBL14996492 0.77 CYP3A4 (0.44) CA12CA2CA9CYP3A4TSHR
SCHEMBL14996527 0.75 CYP2C9 (0.54) SMN1; SMN2CYP3A4TSHRCYP2D6CYP1A2
SCHEMBL11947830 0.75 CA12 (0.41) CA12CA2CA9CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 — — US disclosed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 — — US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles BDKRB1, BDKRB2, BRD1 CA12 4620/4885CA2 2033/4885CA9 3240/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CA12 4297/4885CA2 2311/4885CA9 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback